CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 34 filers reported holding CONATUS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $4,000 | – | 17,539 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kalos Management, Inc. | 47,500 | $12,000 | 0.01% |
| Virtu Financial LLC | 94,842 | $25,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 467,425 | $121,000 | 0.00% |
| REILLY FINANCIAL ADVISORS, LLC | 22,011 | $6,000 | 0.00% |
| A.R.T. Advisors, LLC | 60,430 | $16,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 25,350 | $7,000 | 0.00% |
| MORGAN STANLEY | 1,019 | $0 | 0.00% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 24,900 | $6,000 | 0.00% |
| WOLVERINE TRADING, LLC | 30,900 | $8,000 | 0.00% |
| WOLVERINE TRADING, LLC | 26,779 | $7,000 | 0.00% |